139 related articles for article (PubMed ID: 18022599)
21. Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia.
Schmiegelow K; Ifversen M
Pediatr Hematol Oncol; 1996; 13(5):433-41. PubMed ID: 10897815
[TBL] [Abstract][Full Text] [Related]
22. Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.
Graham ML; Shuster JJ; Kamen BA; Cheo DL; Harrison MP; Leventhal BG; Pullen DJ; Whitehead VM
Cancer Chemother Pharmacol; 1992; 31(3):217-22. PubMed ID: 1464159
[TBL] [Abstract][Full Text] [Related]
23. Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro.
Hum MC; Smith AK; Lark RH; Winick NJ; Kamen BA
Pharmacotherapy; 1997; 17(6):1260-6. PubMed ID: 9399609
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of methotrexate and its metabolites in red blood cells.
Lena N; Imbert AM; Brunet P; Cano JP; Carcassonne Y
Cancer Drug Deliv; 1987; 4(2):119-27. PubMed ID: 2448023
[TBL] [Abstract][Full Text] [Related]
25. Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types.
Korell J; Duffull SB; Dalrymple JM; Drake J; Zhang M; Barclay ML; Stamp LK
Br J Clin Pharmacol; 2014 Mar; 77(3):493-7. PubMed ID: 23844933
[TBL] [Abstract][Full Text] [Related]
26. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.
Masson E; Relling MV; Synold TW; Liu Q; Schuetz JD; Sandlund JT; Pui CH; Evans WE
J Clin Invest; 1996 Jan; 97(1):73-80. PubMed ID: 8550853
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
Angelis-Stoforidis P; Vajda FJ; Christophidis N
Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate Polyglutamate Values in Children and Adolescents With Acute Lymphoblastic Leukemia During Maintenance Therapy.
Kandikonda P; Bostrom B
J Pediatr Hematol Oncol; 2019 Aug; 41(6):429-432. PubMed ID: 31259826
[TBL] [Abstract][Full Text] [Related]
30. Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Salzer WL; Winick NJ; Wacker P; Lu X; Devidas M; Shuster JJ; Mahoney DH; Lauer SJ; Camitta BM
J Pediatr Hematol Oncol; 2012 Jan; 34(1):e1-7. PubMed ID: 21364468
[TBL] [Abstract][Full Text] [Related]
31. Phase I and pharmacokinetic trial of aminopterin in patients with refractory malignancies.
Ratliff AF; Wilson J; Hum M; Marling-Cason M; Rose K; Winick N; Kamen BA
J Clin Oncol; 1998 Apr; 16(4):1458-64. PubMed ID: 9552052
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
[TBL] [Abstract][Full Text] [Related]
33. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease.
Brooks AJ; Begg EJ; Zhang M; Frampton CM; Barclay ML
Ther Drug Monit; 2007 Oct; 29(5):619-25. PubMed ID: 17898653
[TBL] [Abstract][Full Text] [Related]
34. Plasma Distribution of Methotrexate and Its Polyglutamates in Pediatric Acute Lymphoblastic Leukemia: Preliminary Insights.
Rajšić I; Lazarević S; Đanić M; Al-Salami H; Mooranian A; Vukmirović S; Mikov M; Goločorbin-Kon S
Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):127-134. PubMed ID: 34637107
[TBL] [Abstract][Full Text] [Related]
35. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
Dalrymple JM; Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Barclay ML
Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
[TBL] [Abstract][Full Text] [Related]
37. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate analogues. 19. Replacement of the glutamate side chain in classical antifolates by L-homocysteic acid and L-cysteic acid: effect on enzyme inhibition and antitumor activity.
Rosowsky A; Forsch RA; Freisheim JH; Moran RG; Wick M
J Med Chem; 1984 May; 27(5):600-4. PubMed ID: 6546949
[TBL] [Abstract][Full Text] [Related]
39. Role of polyglutamates in methotrexate action.
Wilmanns W; Schalhorn A
Chemioterapia; 1985 Oct; 4(5):349-53. PubMed ID: 2416481
[TBL] [Abstract][Full Text] [Related]
40. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]